Skip to main content
. 2024 Sep 12;16(18):3078. doi: 10.3390/nu16183078

Figure 1.

Figure 1

Schematic diagram of cross-over study design (A) and experimental protocol during the 2nd and 3rd visits (B). AA = arachidonic acid; CK = creatine phosphokinase; CRP = C-reactive protein; DHA = docosahexaenoic acid; MS = muscle soreness; EPA = eicosapentaenoic acid; GI = gastrointestinal; IL-6 = interleukin-6; WBC = white blood cells.